 Embark got its start at the Novo Nordisk Foundation Center for Basic Metabolic Research where research conducted by Zach GerhartHines Jakob Bondo Hansen and Thue Schwartz gained seed backing from Novo Holdings and a collaboration with Novo Nordisk itself